Janice Chen

Co-founder & CTO at Mammoth Biosciences | San Francisco, California, United States

About Janice Chen

Janice Chen, as the co-founder and Chief Technology Officer of Mammoth Biosciences, is at the forefront of revolutionizing biotechnology through innovative CRISPR technologies. With a robust background in molecular biology and biochemistry, Janice leads a talented team dedicated to unlocking the potential of novel CRISPR systems that can detect and cure diseases. Her expertise in protein purification, protein bio-conjugation, and in vitro transcription plays a crucial role in the development of Mammoth's cutting-edge diagnostic tools and therapeutic applications.

Under Janice's leadership, Mammoth has embarked on several key projects that exemplify the company's mission to harness the diversity of nature. One of the flagship initiatives includes the development of a CRISPR-based platform capable of rapid and accurate disease detection, which has significant implications for public health, especially in the context of emerging infectious diseases. Janice's proficiency in techniques such as FRET and column chromatography has been instrumental in optimizing the performance of these CRISPR systems, ensuring they are not only effective but also scalable for widespread use.

Moreover, Janice is passionate about mentoring the next generation of scientists, fostering an environment of collaboration and innovation within the company. Her commitment to advancing the field of biotechnology is evident in her efforts to bridge the gap between scientific discovery and practical application, positioning Mammoth Biosciences as a leader in the CRISPR landscape. Through her vision and expertise, Janice Chen is not just contributing to the scientific community; she is shaping the future of healthcare and disease management.

Janice Chen Work